News Releases | Olink Holding AB

Date	Title
Jul 12, 2021	Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders
Jun 23, 2021	Olink announces the new Explore 3072 high throughput proteomics platform, offering uncompromised data quality with coverage of all major biological pathways
Jun 15, 2021	Olink: SCALLOP launches clinical trial arm to uncover next level of drug target insights from proteomic profiling
Jun 02, 2021	Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedicated to multiplex protein biomarker measurement
May 25, 2021	Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference
May 20, 2021	Olink reports first quarter 2021 financial results and issues full year 2021 guidance
May 04, 2021	Olink announces first core lab running the Olink Explore platform in Europe, making it available for more researchers
Apr 29, 2021	Olink to Report First Quarter 2021 Financial Results on May 20, 2021
Mar 24, 2021	Olink Holding AB (publ) Announces Pricing of Initial Public Offering
Dec 07, 2020	Olink to provide proteomics data from 53,000 UK Biobank participants
Sep 29, 2020	Genosity and Olink Proteomics announce strategic collaboration
Sep 18, 2020	Data publicly released to the global research community from the largest proteomics study on COVID-19 – a collaboration between Massachusetts General Hospital and Olink
Jul 08, 2020	WuXi NextCODE and Olink Proteomics announce strategic cooperation
Jun 03, 2020	Proteomics on NGS: The launch of Olink Explore 1536 will be a game changer
May 12, 2020	Olink acquires Agrisera AB
Mar 12, 2019	Summa Equity acquires Olink Proteomics
Dec 13, 2018	Olink Proteomics announces a new oncology-focused biomarker panel that expands its protein library to over 1100 high-quality assays
Aug 31, 2018	Olink Proteomics announces a new biomarker panel that expands its protein library to over 1000 high-quality assays
Dec 14, 2017	Olink Proteomics announces the availability of the most comprehensive, high-multiplex protein biomarker panel for mouse studies
Feb 14, 2017	Olink Proteomics announces the availability of three additional biomarker panels focused on key biological processes with broad clinical relevance